Looks like you are not TradeKey.com's Member yet. Signup now to connect with over 10 Million Importers & Exporters globally.
Join Now, its Free |
User Sign In Join Free
Live Chat Live Chat
❯
BOOK A CALL
Book Call On Your Favorite Time

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

❯
Contact Us
product
Prev
3-iodo-6-nitro-1-(tetrahydropyran-2-yl)-1H-indazole
Next

3-iodo-6-nitro-1-(tetrahydropyran-2-yl)-1H-indazole

FOB Price

Get Latest Price

( Negotiable )

|

100 Gram Minimum Order

Country:

China

Model No:

IP0004-G

FOB Price:

( Negotiable ) Get Latest Price

Place of Origin:

china

Price for Minimum Order:

-

Minimum Order Quantity:

100 Gram

Packaging Detail:

Aluminum foil bag, PTFE Bottle, or meet your requirment

Delivery Time:

Within one week

Supplying Ability:

1 Kilogram per Month

Payment Type:

D/P, L/C, T/T

Product Group :

Pharma intermediate

Contact Now
Shanghai Yudiao Chemistry Technology Co., Ltd

Shanghai Yudiao Chemistry Technology Co., Ltd

China

Free Member

Contact Person Mr. James

Building A, NO.688,Qiushi Road,Jinshan District, Shanghai, shanghai

Contact Now

Product Specification

  • Other Names: 3-iodo-6-nitro-1-(tetrahydropyran-2-yl)-1H-indazole
  • Type: Pharmaceutical Intermediates
  • Purity (%): 99%
  • Brand Name: YD
  • Application: pharm intermediate
  • Appearance: white powder

Product Description

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug is being investigated as a single dose therapy, as well as in combination with chemotherapy.Pfizer submitted a new drug application for the treatment of advanced renal cell carcinoma based on the Phase III AXIS ***2 trial.The drug has been approved for review by the FDA in June ***1.The drug was also accepted for review by the European Medicines Agency in June ***1.The review will be based on the Phase III AXIS ***2 trial.More than **0,**0 people are diagnosed with renal cell carcinoma every year and **2,**0 people die as a result of the cancer.

Country: China
Model No: IP0004-G
FOB Price: ( Negotiable ) Get Latest Price
Place of Origin: china
Price for Minimum Order: -
Minimum Order Quantity: 100 Gram
Packaging Detail: Aluminum foil bag, PTFE Bottle, or meet your requirment
Delivery Time: Within one week
Supplying Ability: 1 Kilogram per Month
Payment Type: D/P, L/C, T/T
Product Group : Pharma intermediate

Related Products Shanghai Yudiao Chemistry Technology Co., Ltd

raltegravir (free base) API raltegravir (free base) API
raltegravir k salt raltegravir k salt
(E)-6-nitro-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole (E)-6-nitro-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
(E)-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine (E)-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine
(E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole (E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
(E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-ylthio)benzamide (E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-ylthio)benzamide
2-mercapto-N-methylbenzamide 2-mercapto-N-methylbenzamide
Axitinib API Axitinib API
masitinib API masitinib API
1-Methyl-5-nitro-1H-benzimidazole-2-butanoic acid ethyl ester 1-Methyl-5-nitro-1H-benzimidazole-2-butanoic acid ethyl ester
bendamustine HCl API bendamustine HCl API
(S)-tert-butyl 3-oxo-1-phenylpropylcarbamate (S)-tert-butyl 3-oxo-1-phenylpropylcarbamate
maraviroc API maraviroc API
2-Amino-2-methylpropane nitrile 2-Amino-2-methylpropane nitrile

Related Products

Send a direct inquiry to this supplier

To:

Mr. James < Shanghai Yudiao Chemistry Technology Co., Ltd >

I want to know:

Get Verified Buyers & Suppliers

Avail Free Consultation

By Signing up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

no thanks